Span Divergent FY26 Results Show Standalone Profit Amidst Wider Consolidated Loss

Span Divergent Limited reported a standalone net profit of ₹0.73 crore for the year ended March 31, 2026. However, the company's consolidated net loss widened to ₹2.95 crore during the same period.

Reader Takeaway: Profitable parent company contrasts with escalating subsidiary losses; turnaround strategy crucial.

What just happened

Span Divergent Limited's standalone net profit for the fiscal year 2026 stood at ₹72.64 lakh (₹0.7264 crore). This is a decrease of 13.48% from ₹83.96 lakh in FY 2025. Standalone total income also fell by 19.47% to ₹222.42 lakh (₹2.2242 crore).

On a consolidated basis, the company reported a net loss of ₹294.72 lakh (₹2.9472 crore) for FY 2026. This represents a widening of the loss from ₹127.37 lakh (₹1.2737 crore) in FY 2025. Consolidated total income, however, surged by 82.40% to ₹1,851.08 lakh (₹18.5108 crore).

The company's auditor issued an unmodified opinion, and Span Divergent is not classified as a 'Large Corporate'.

Why this matters

The divergence between standalone profitability and consolidated losses indicates that the company's subsidiaries are a significant drag on overall financial performance. The widening consolidated loss, despite a substantial increase in consolidated revenue, is a key concern for investors.

The backstory

For the fiscal year 2025, Span Divergent had reported a standalone net profit of ₹83.96 lakh and a consolidated net loss of ₹127.37 lakh. The FY26 results show continued standalone profitability but a more severe consolidated loss.

What changes now

Investors will be closely watching the management's execution of turnaround strategies for its loss-making subsidiaries. The company's ability to improve subsidiary performance will be critical for future consolidated earnings.

Risks to watch

• Subsidiary Solvency: Biospan Contamination Control Solution Pvt. Ltd. faces solvency issues with a negative net worth of ₹7.10 crore.
• Accumulated Losses: Significant accumulated losses in subsidiaries like Aranya Consulting and Biotech LLP and Biospan Contamination Control continue to impact group earnings.
• Turnaround Uncertainty: The success of management's plans to revive loss-making entities hinges on unproven future product launches and market acceptance.

Segment Performance (Consolidated FY 2026)

• Cashew processing: Revenue of ₹1,367.57 lakh with a loss of ₹269.22 lakh.
• Tissu Culture: Revenue of ₹24.94 lakh with negligible profit/loss.
• Trading: Revenue of ₹364.16 lakh with a loss of ₹73.89 lakh.

Context metrics (time-bound)

• FY 2026 Standalone Net Profit: ₹0.73 crore
• FY 2026 Consolidated Net Loss: ₹2.95 crore
• FY 2025 Standalone Net Profit: ₹0.84 crore
• FY 2025 Consolidated Net Loss: ₹1.27 crore

What to track next

Investors should monitor upcoming quarterly results for signs of improvement in subsidiary performance and the impact of management's revival strategies. The solvency of Biospan Contamination Control Solution Pvt. Ltd. and the overall reduction in accumulated losses will be key indicators.